GLUE
Monte Rosa Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.66
+9.45%Leverage
- Debt / equity
- 0.08x
- Net debt / equity
- -0.11x
- Debt / assets
- 0.05x
- Debt / EBITDA
- -0.24x
- Net debt / EBITDA
- 0.33x
Liquidity & coverage
- Current ratio
- 9.52x
- Quick ratio
- 9.52x
- Cash ratio
- 9.30x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $569.5M
Cash & dividend
- FCF / debt
- -0.84x
- Cash flow / debt
- -0.63x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026